Colivelin TFA is primarily used in neuroscience research for its neuroprotective properties. It has been studied for its potential to prevent neuronal cell death in models of neurodegenerative diseases such as Alzheimer's disease. The compound demonstrates the ability to reduce amyloid-beta-induced toxicity, a key factor in Alzheimer's pathology. It also enhances cognitive function in animal models by promoting synaptic activity and memory retention. Due to its stability and cell-penetrating ability, Colivelin TFA is favored in experimental settings for evaluating neuroprotection and cognitive enhancement. It is not used clinically but serves as a valuable tool in understanding mechanisms of neurodegeneration and identifying potential therapeutic targets.